Your Complete Guide to Global Clinical Research and GCP Compliance
KRIs, KPIs and Dashboards to Monitor Publication Policies & Authorship Criteria Across Portfolios KRIs, KPIs and Dashboards to Monitor Publication Policies & Authorship Criteria Across Portfolios Introduction to KPIs, KRIs, and Dashboards in Clinical Research Management In clinical research, especially in the realms governed by rigorous regulatory standards such as those from the FDA, EMA,…
Case Studies: Publication Policies & Authorship Criteria That Strengthened Public and Regulator Trust The increasing emphasis on clinical trial transparency is essential for enhancing public trust and regulatory confidence. The presence of robust publication policies and well-defined authorship criteria is instrumental in ensuring that both scientific integrity and ethical standards are maintained. This article will…
Digital Tools and Automation to Streamline Publication Policies & Authorship Criteria Digital Tools and Automation to Streamline Publication Policies & Authorship Criteria The integration of digital tools and automation into clinical trial processes is transforming the way publication policies and authorship criteria are managed. In a regulatory landscape governed by ICH-GCP standards, as well as…
Read More “Digital Tools and Automation to Streamline Publication Policies & Authorship Criteria” »
Inspection and Audit Readiness: Documenting Publication Policies & Authorship Criteria for Regulators Inspection and Audit Readiness: Documenting Publication Policies & Authorship Criteria for Regulators In the increasingly regulated world of clinical trials, ensuring compliance with the ever-evolving standards is paramount. Not only do regulatory bodies like the FDA and EMA enforce guidelines for conducting clinical…
Aligning Publication Policies & Authorship Criteria With ICH, GCP and Transparency Regulations In the complex landscape of clinical research, especially concerning Crohn’s disease clinical trials, it is critical for professionals in clinical operations, regulatory affairs, and medical affairs to understand the integration of publication policies and authorship criteria with current regulations and guidelines. This article…
Publication Policies & Authorship Criteria Playbook for High-Profile and Late-Phase Trials Publication Policies & Authorship Criteria Playbook for High-Profile and Late-Phase Trials The integrity and transparency of clinical trials, especially in the context of ulcerative colitis clinical trials, are paramount in post-trial publication and dissemination of results. This guide is designed for clinical operations, regulatory…
Publication Policies & Authorship Criteria in Practice: Step-by-Step Guide for Sponsors and CROs Publication Policies & Authorship Criteria in Practice: Step-by-Step Guide for Sponsors and CROs Effective communication of clinical trial results is critical for the advancement of medical science, regulatory compliance, and ethical publication practices. For sponsors and Contract Research Organizations (CROs), understanding publication…
Common Pitfalls in Publication Policies & Authorship Criteria—and How to Avoid Costly Findings Common Pitfalls in Publication Policies & Authorship Criteria—and How to Avoid Costly Findings In the realm of clinical research, ensuring adherence to publication policies and authorship criteria is essential for maintaining the integrity and credibility of research outcomes. This is particularly crucial…
Publication Policies & Authorship Criteria: Compliance Strategy for US, EU and UK Clinical Programs Publication Policies & Authorship Criteria: Compliance Strategy for US, EU and UK Clinical Programs The role of publication policies and authorship criteria in clinical trials is vital for maintaining the integrity and transparency of research findings. Adherence to strict guidelines is…
How to Design Publication Policies & Authorship Criteria That Meets FDA, EMA and MHRA Expectations How to Design Publication Policies & Authorship Criteria That Meets FDA, EMA and MHRA Expectations In the evolving landscape of clinical research, particularly concerning clinical trials for small cell lung cancer and other serious diseases, it becomes vital for clinical…
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.